On the recordMarch 7, 2012
Encouraging drug development to combat infections that arise from Gram-negative pathogens like Iraqibacter is an appropriate role for Congress and the FDA.
Source
congress.govEditor's note · Context
Gingrey supports congressional action on drug development for serious infections.
Share & report
More from Phil Gingrey
Mar 12, 2013
We're afraid to grow. The lack of information is creating fear, and it's not good for the economy.
Apr 10, 2013
I think at this point it is incredibly important for Congress to do the same thing, to engage seniors on the urgency of Medicare's fiscal situation.
Jul 18, 2012
I fully support H. Con. Res. 132. This, of course, would ensure the printing and production of Hispanic Americans in Congress.
Other voices in this conversation
